We’ve all seen the pink ribbons. Some of us have even worn them while others have intimate, personal knowledge of the disease. Many have donated to it. Some treat it while others study it. Each of us in these various roles is part of that pink ribbon family, committed to doing whatever we can to change the outcome for all those affected by it. To this end, precision medicine holds enormous promise with the ultimate goal of treating each patient individually by approaching breast cancer disease as an “n” of one.

For the full blog and history of advances in breast cancer, please go to the site it was originally posted:

https://www.massbio.org/news/blog/the-promise-of-precision-medicine-for-breast-cancer-143910

By | 2018-07-10T18:27:38+00:00 July 10th, 2018|Uncategorized|0 Comments

About the Author:

Loralyn is the team translator with nearly 20 years of experience listening to what scientists need and to what software developers say they can build, liaising between the two groups to drive product development and messaging so that both sides get what they need – and want. Loralyn has held a variety of roles within the life sciences anchored in market development for analytics and ‘omics technologies. She brings a combination of marketing, alliance management, sales and innovation to the company. Her specialty is connecting the dots aligning needs to products to people with a personal mission to help others and upholds the philosophy that better tools = better health.

Leave A Comment